Drawing for NANOTEMPER

USPTO serial 85040691

NANOTEMPER

Reviewed by CopyMark Law Group

Reg. 4223921Status 800Registered
Filing date
Status date
Registration date
Oct 16, 2012
Examiner
JENKINS JR, CHARLES L
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with NANOTEMPER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian J. Focarino

Brian J. Focarino COOLEY LLP1299 PENNSYLVANIA AVENUE NW, SUITE 700ATTN: IP Docketing DepartmentWASHINGTON, DC 20004

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and agriculture; [ chemical substances for preserving foodstuffs; ] biochemical compounds, namely, peptides, peptide derivatives, proteins, antibodies, fragments of antibodies, derivatives of antibodies, nucleic acids, vectors, cells, cellular components, micro particles used to detect and analyze interactions, enzymatic processes, toxins, diseases for laboratory and research use; diagnostic kits, consisting primarily of [ monoclonal antibodies, ] buffers and reagent to monitor toxicity of drugsACTIVE—
005[ Pharmaceutical preparations for the treatment and detection of cardiovascular diseases, the gout, heart rhythm disorders, lung diseases, thymus gland diseases, tumors, skin disorders, fecal occult blood, diabetes, inflammation, auto-immune diseases and endocrinological diseases; veterinary preparations for the treatment of cats, dogs, cows, horses snakes, fishes; sanitary preparations for medical use; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; diagnostic preparations for medical or veterinary use, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; reagents and media, namely, solvents, buffers, nucleic acids, proteins, macromolecules and biologically active substances for medical and veterinary diagnostic purposes; drug testing kits comprised of medical diagnostic reagents, assays, nucleic acids, proteins, macromolecules and biologically active substances for testing body fluids; medicaments for treating skin disorders, internal illnesses, drug target compositions for treating cardiovascular diseases, the gout, heart rhythm disorders, lung diseases, thymus gland diseases, tumors, skin disorders, fecal occult blood, diabetes, inflammation, auto-immune diseases and other endocrinological or internal diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; in vitro gender prediction test kits; in vitro ovulation prediction test kit for home use ]SECTION 8 - CANCELLED—
009Scientific apparatus, namely, electro-optical instruments for measurement of fluorescence, comprising a fluorescence excitation light source, optical mirrors, an optical detector and an infrared light source for research and diagnostic purposes; data processors and part therefore; computer hardware; computer software for data collection and data evaluation, database management and automated, semi automated and manual data processing; analytical devices, namely, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific apparatus, namely, optical instruments that use fluorescence; computer operating systems for the collection and administration of diagnostically or medically relevant data; downloadable electronic publications in the nature of handbooks, manuals, informational and marketing material that are published electronically or as hardcopy in the field of science, diagnostics, pharmaceutical development, food or agricultural technologyACTIVE—
010[ Surgical apparatus and instruments for medical, dental or veterinary use; artificial limbs, eyes, and teeth; medical, namely, orthopedic apparatus and instruments; suture materials; medical products, namely, biofeedback sensors; diagnostic apparatus for the detection of cancer; sample preparation device for medical diagnostic uses ]SECTION 8 - CANCELLED—
042Scientific research and technological services, namely, interaction studies, binding studies, activity studies, specificity studies of biomolecules in the field of basic research, industrial research, life sciences, biology, biochemistry, drug development, biotechnology, food technology research in the field of genetics, proteomics, metabolonomics; design and development of computer hardware and software; medical, biological, molecular genetic, chemical, diagnostic, food technological and pharmaceutical research; scientific laboratory services; biochemical, biological, molecular genetic, food technological and diagnostic consulting for scientific purposes; diagnostic services in the field of electro-optical instruments for measurement of fluorescence, comprising a fluorescence excitation light source, optical mirrors, an optical detector and an infrared light source; pharmaceutical drug development services; medical and scientific research, namely, conducting, medical, biological, molecular genetic, chemical, diagnostic, food technological and pharmaceutical research; biochemical, biological, molecular genetic, food technological and diagnostic consulting for scientific purposes; computer programming; design and maintenance of computer software; updating of database software; development of computer software systems for the collection of relevant biological data, namely, interaction mapping, inhibitor classification; Scientific and industrial research, namely, collection, processing, propagation and analysis of biomaterials and medically or diagnostically relevant dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 28, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 15, 2022NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Oct 15, 2022RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Oct 15, 202289AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Oct 13, 2022E89RTEAS SECTION 8 & 9 RECEIVED—
Oct 16, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Oct 30, 2018NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 30, 2018C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 30, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 15, 2018E815TEAS SECTION 8 & 15 RECEIVED—
Oct 16, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 9, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 16, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 6, 2012DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Aug 29, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 28, 2012IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 28, 2012D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Feb 28, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 3, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 3, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 30, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 30, 2011COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 29, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 22, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 22, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Nov 22, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Nov 22, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 22, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 22, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 22, 2011ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 14, 2011PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 3, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 2, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 2, 2011COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 1, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Nov 1, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Nov 1, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 1, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 1, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 28, 2011DMCCDATA MODIFICATION COMPLETED—
Apr 25, 2011GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 25, 2011GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 25, 2011CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 29, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 29, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2011ALIEASSIGNED TO LIE—
Mar 10, 2011MAILPAPER RECEIVED—
Sep 7, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2010DOCKASSIGNED TO EXAMINER—
May 27, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
May 26, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 20, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance